kısım 1 temel kalp yetersizliÄi - Rasim Enar
kısım 1 temel kalp yetersizliÄi - Rasim Enar
kısım 1 temel kalp yetersizliÄi - Rasim Enar
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
136<br />
KANITA DAYALI KALP YETERSİZLİĞİ KİTABI<br />
EL1TE II: Evaluation of Losartan in the Elderly Trial H.<br />
Pitt B, Poole-Wilson PA, Segal R, et al. Effect of losartan compared<br />
with captopril on mortality in patients with symptomatic<br />
heart failure: randomized trial; the Losartan Heart Failure Survival<br />
Study ELITE II. Lancet 2000;355(9215):1582-1587.<br />
EMIAT: European Amiodarone Myocardial infarction Arrhythmia<br />
Trial. Julian DG, Camm AJ, Frangin G, et al. Randomized<br />
trial of effect of amiodarone on mortality in patients with<br />
left-ventricular dysfunction after recent myocardial infarction:<br />
EMIAT. European Myocardial Infarct Amiodarone Trial Investigators.<br />
Lancet 1997;349(9053):667-674.<br />
EPHESUS: Epleronone Post-Acute Myocardial infarction Heart<br />
Failure Efficacy and Survival Study.<br />
Pitt B, Remme W, Zannad F, et al. Eplerenone Post-Acute Myocardial<br />
infarction Heart Failure Efficacy and Survival Study<br />
Investigators. Eplerenone, a selective aldosterone blocker, in<br />
patients with left ventricular dysfunction after myocardial infarction.<br />
N. Engl. J. Med. 2003;348(14):1309-1321.<br />
EXPEDITION: Sodium-Proton Exchange Inhibition to Prevent<br />
Coronary Events in Acute Cardiac Conditions Trial.<br />
Mentzer RM Jr. Presentation at American Heart Association<br />
Scientific Sessions 2003.<br />
Framingham Study:<br />
Ho KK, Pinsky JL, Kannel WB, Levy D. The epidemiology<br />
of heart failure: the Framingham Study. /. Am. Coll. Cardiol.<br />
1993;22(4 Suppl A):6A-13A.<br />
GESICA: Doval HC, Nul DR, Grancelli HO, Perrone SV, Bortman<br />
GR, Curiel R. Randomized trial of low-dose amiodarone<br />
in severe congestive heart failure. Grupo de Estudio de la<br />
Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA).<br />
Lancet 1994;344(8921):493-498.<br />
GISSI-3: Gruppo Italiano per lo Studio della Sopravvivenza<br />
nell’infarto Miocardico.<br />
GISSI-3 Investigators. GISSI-3: effects of lisinopril and transdermal<br />
glyceryl trinitrate singly and together on 6-week<br />
mortality and ventricular function after acute myocardial infarction.<br />
Gruppo Italiano per lo Studio della Sopravvivenza<br />
nell’infarto Miocardico. Lancet 1994;343(8906):1115-İ122.<br />
HOPE: Heart Outcomes Prevention Evaluation.<br />
Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G.<br />
Effects of an angiotensin-converting enzyme inhibitor, ramipril,<br />
on cardiovascular events in high-risk patients. The Heart<br />
Outcomes Prevention Evaluation Study Investigators. N.<br />
Engl. J. Med. 2000;342(3):145-153. Erratum in: N. Engl. J. Med.<br />
2000;342(18):1376; N. Engl. J. Med. 2000;342(10):748.<br />
IONA: Impact of Nicorandil in Angina.<br />
IONA Study group. Effect of nicorandil on coronary events in<br />
patients with stable angina: the Impact Of Nicorandil in Angina<br />
(IONA) randomized trial. Lancet 2002;359(9314):1269-1275.<br />
Erratum in: Lancet 2002;360(9335): 806.<br />
ISIS-4: Fourth International Study of Infarct Survival<br />
ISIS-4 (Fourth International Study of Infarct Survival) Colla-<br />
borative Group. ISIS-4: a randomized factorial trial assessing<br />
early oral captopril, oral mononitrate, and intravenous magnesium<br />
sulphate in 58,050 patients with suspected acute myocardial<br />
infarction. Lancet 1995;345(8951):669-685.<br />
LIDO: Levosimendan Infusion versus DObutamine in severe<br />
congestive heart failure. Follath F, Cleland JGF, Just H, et al.<br />
Efficacy and safety of intravenous levosimendan compared<br />
with dobutamine in severe low-output heart failure (the LIDO<br />
study): a randomized double-blind trial. Lancet 2002;360:196-<br />
202.<br />
MDC: Metoprolol in Dilated Cardiomyopathy Study. Metoprolol<br />
in Dilated Cardiomyopathy (MDC) Trial Study Group.<br />
Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy.<br />
Lancet 1993;342:1441-1446.<br />
MERIT-HF: Metoprolol CR/XL Randomized Intervention<br />
Trial in Congestive Heart Failure.<br />
MERJT-HF Investigators. Effect of metoprolol CR/XL in chronic<br />
heart failure: Metoprolol CR/XL Randomized Intervention<br />
Trial in Congestive Heart Failure (MERIT-HF). Lancet<br />
1999;353(9169):2001-2007.<br />
Minnesota Living with Heart Failure Questionnaire.<br />
Rector TS, Cohn JN. Assessment of patient outcome with the<br />
Minnesota Living with Heart Failure questionnaire: reliability<br />
and validity during a randomized, double-blind, placebo-controlled<br />
trial of pimobendan. Pimobendan Multicenter Research<br />
Group. Am. Heart]. 1992;124(4):1017-1025.<br />
MONICA: MONitoring trends and determinants in GArdiovascular<br />
disease.<br />
McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic<br />
and asymptomatic LVSD in an urban population. Lancet<br />
1997;350:829-833.<br />
PRAISE: Prospective Randomized Amlodipine Survival Evaluation.<br />
Packer M, O’Connor CM, Ghali JK, et al. for the Prospective<br />
Randomized Amlodipine Survival Evaluation Study Group.<br />
Effect of amlodipine on morbidity in severe chronic heart failure.<br />
N. Engl. J. Med. 1996;335(15):1107-1114.<br />
PRİME II: Second Prospective Randomized Study of Ibopamine<br />
on Mortality and Efficacy.<br />
Hampton JR, van Veldhuisen DJ, Kleber FX, et al. Randomized<br />
study of effect of ibopamine on survival in patients with advanced<br />
severe heart failure. Second Prospective Randomized<br />
Study of Ibopamine on Mortality and Efficacy (PRİME II) Investigators.<br />
Lancet 1997;349(9057):971-977.<br />
PROMISE: Prospective Randomized Milrinone Survival<br />
Evaluation.<br />
Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone<br />
on mortality in severe chronic heart failure. The PROMISE<br />
Study Research Group. N. Engl. J. Med. 1991;325(21):1468-1475.<br />
PROVED: Prospective Randomized study Of Ventricular failure<br />
and the Efficacy of Digoxin. Uretsky BF, Young JB, Shahidi<br />
FE, Yellen LG, Harrison MC, Jolly MK. Randomized study
Change language